DRUG BRIGHT MINDS BIOSCIENCES INC.

Nasdaq brightmindsbio.com


$ 61.79 $ -0.65 (-1.05 %)    

Thursday, 23-Oct-2025 15:59:53 EDT
QQQ $ 611.66 $ 5.09 (0.84 %)
DIA $ 467.15 $ 1.51 (0.32 %)
SPY $ 672.20 $ 3.96 (0.59 %)
TLT $ 91.48 $ -0.63 (-0.68 %)
GLD $ 379.02 $ 1.51 (0.4 %)
$ 61.54
$ 62.15
$ 59.88 x 1
$ 65.49 x 102
$ 61.05 - $ 64.60
$ 23.18 - $ 70.23
204,365
na
278.41M
$ 2.83
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

https://www.marijuanamoment.net/psychedelics-show-promise-as-an-entirely-new-type-of-anti-inflammatory-treatment-research-sugge...

Core News & Articles

https://www.marijuanamoment.net/new-york-lawmakers-hold-hearing-psilocybins-medical-benefits-amid-broader-debate-over-psychedel...

 hc-wainwright--co-reiterates-buy-on-bright-minds-biosciences-maintains-85-price-target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Bright Minds Biosciences (NASDAQ:DRUG) with a Buy and maintai...

Core News & Articles

https://www.marijuanamoment.net/massachusetts-lawmakers-approve-bill-to-create-psychedelic-therapy-pilot-program/

 large-patient-population-is-key-driver-for-bright-minds-growth

BTIG initiates coverage on Bright Minds Biosciences with a Buy rating, citing BMB‑101's potential and key Phase 2 data expe...

 btig-initiates-coverage-on-bright-minds-biosciences-with-buy-rating-announces-price-target-of-72

BTIG analyst Thomas Shrader initiates coverage on Bright Minds Biosciences (NASDAQ:DRUG) with a Buy rating and announces Pri...

Core News & Articles

https://www.marijuanamoment.net/military-to-start-testing-service-members-for-the-psychedelic-psilocin-memo-shows/

Core News & Articles

https://www.marijuanamoment.net/gop-senator-is-confident-psychedelics-access-will-expand-under-trump-saying-many-veterans-speak...

 hc-wainwright--co-reiterates-buy-on-bright-minds-biosciences-maintains-85-price-target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Bright Minds Biosciences (NASDAQ:DRUG) with a Buy and maintai...

Core News & Articles

https://www.marijuanamoment.net/massachusetts-psychiatric-society-endorses-bill-to-decriminalize-psilocybin-possession/

Core News & Articles

https://www.marijuanamoment.net/california-governor-hes-all-in-on-psychedelic-therapy-access-but-worries-about-capitalists-comm...

Core News & Articles

https://www.washingtonpost.com/health/2025/07/16/psychedelics-rfk-jr-kennedy-ibogaine-mdma/41658b06-6246-11f0-bf70-56d8888ebb94...

Core News & Articles

https://www.foxnews.com/health/key-living-longer-could-tied-surprising-substance-study-suggests

 cantor-fitzgerald-assumes-bright-minds-biosciences-at-overweight

Cantor Fitzgerald analyst Pete Stavropoulos assumes Bright Minds Biosciences (NASDAQ:DRUG) with a Overweight rating.

Core News & Articles

https://www.bloomberg.com/news/articles/2025-06-30/colorado-moves-to-allow-hallucinogen-ibogaine-for-medical-use?embedded-check...

Core News & Articles

https://www.marijuanamoment.net/house-votes-to-let-va-doctors-recommend-medical-mari

Core News & Articles

https://www.marijuanamoment.net/rfk-says-trump-administration-could-provide-psychedelic-therapy-to-military-veterans-within-12-...

Core News & Articles

https://www.statnews.com/2025/06/18/fda-approval-psychedelics-rfk-jr-trump-allies-see-opening-mdma-psilocybin-mental-health-tre...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION